Protagonist Therapeutics
PTGX
#2241
Rank
ยฃ6.31 B
Marketcap
ยฃ96.76
Share price
2.00%
Change (1 day)
50.74%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): ยฃ0.94

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ0.93. In 2025 the company made an earnings per share (EPS) of -ยฃ1.56 a decrease over its 2024 EPS that were of ยฃ3.41.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ0.94-159.99%
2025-ยฃ1.56-145.76%
2024ยฃ3.41-402.7%
2023-ยฃ1.13-43.08%
2022-ยฃ1.98-3.7%
2021-ยฃ2.0535%
2020-ยฃ1.52-33.33%
2019-ยฃ2.2874.42%
2018-ยฃ1.31-20.74%
2017-ยฃ1.65-45.64%
2016-ยฃ3.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ1.03-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA